Kidney surgery bleeding study pulled before it started
NCT ID NCT07284953
First seen Jan 07, 2026 · Last updated Apr 29, 2026 · Updated 19 times
Summary
This study aimed to see if a material called PuraBond could safely and effectively stop bleeding during robotic partial nephrectomy for kidney cancer. It was designed for adults undergoing this surgery. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Royal Wolverhampton NHS Trust
Wolverhampton, WV10 0QP, United Kingdom
Conditions
Explore the condition pages connected to this study.